Literature DB >> 19239779

Pertussis in Afghanistan, 2007-2008.

Rishtya M Kakar, Mohammad K Mojadidi, Jawad Mofleh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19239779      PMCID: PMC2681118          DOI: 10.3201/eid1503.080982

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Recent reports have raised concerns about transmission of pertussis among troops stationed in Afghanistan and indicated lack of data about pertussis in this country (,). To fill the knowledge gap about pertussis in Afghanistan, we analyzed data collected by the new Disease Early Warning System (DEWS) during Afghan Year 1386, which corresponds to March 21, 2007–March 20, 2008 () (Figure).
Figure

Suspected pertussis cases recorded at sentinel sites and from outbreaks, Afghanistan, April 2007–March 2008.

Suspected pertussis cases recorded at sentinel sites and from outbreaks, Afghanistan, April 2007–March 2008. DEWS collects weekly data on 15 epidemic-prone diseases from 129 sentinel sites, mostly provincial and district hospitals, based on surveillance case definitions of the World Health Organization. The case definition for suspected pertussis is “a person with a cough lasting at least two weeks and having paroxysms of coughing; or inspiratory ‘whoop’; or post-tussive vomiting and without other apparent cause.” During the study period, 718 cases meeting the surveillance definition for suspected pertussis were recorded in weekly reports from patient visits at DEWS sentinel sites. When a geographic cluster of at least 5 cases of pertussis is suspected in any area, the DEWS team travels to the area and either confirms that cases meet the clinical definition or rejects the outbreak alert. During outbreak response, DEWS personnel record all cases on a linelist (a rough database), collect throat swabs for laboratory culture, treat case-patients and susceptible contacts (infants and pregnant women) with erythromycin, and schedule follow-up vaccination services for the area. During the study period, the team responded to 56 outbreaks of pertussis in the field that involved 2,233 suspected cases and 32 deaths. Despite difficult geographic features and lack of infrastructure, DEWS collected and transported 203 specimens from patients with suspected pertussis to the Central Public Health Laboratory in Kabul where Bordetella pertussis was successfully isolated in bacteriologic culture from 7 (≈3%) of the specimens. This finding compares with that of a recent study from Spain in which 7% of specimens were microbiologically confirmed (). In 75% of the outbreak areas, vaccination coverage was <50%, and median age of patients with suspected cases was 4 years. Thus, Afghanistan needs to continue its focus on raising immunization coverage to >90% by administering the primary series of diphtheria-pertussis-tetanus vaccine to infants. This effort will help reduce transmission among infants and young children for whom pertussis is most lethal ().
  4 in total

1.  Pertussis vaccines--WHO position paper.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2005-01-28

2.  Incidence trends in pertussis in the Autonomous Region of Madrid, Spain: 1982-2005.

Authors:  I Vera; L García-Comas; M Ordobás; A Gutiérrez; J C Sanz; D Barranco
Journal:  Euro Surveill       Date:  2007-09-01

3.  Pertussis -- a case finding study amongst returnees from Op Herrick.

Authors:  N K Cooper; M C M Bricknell; G R Holden; C McWilliam
Journal:  J R Army Med Corps       Date:  2007-06       Impact factor: 1.285

4.  Outbreak of pertussis, Kabul, Afghanistan.

Authors:  Emmanuel Sagui; Lénaïck Ollivier; Tiphaine Gaillard; Fabrice Simon; Patrick Brisou; Philippe Puech; Alain Todesco
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

  4 in total
  1 in total

1.  The burden of laboratory-confirmed pertussis in low- and middle-income countries since the inception of the Expanded Programme on Immunisation (EPI) in 1974: a systematic review and meta-analysis.

Authors:  Rudzani Muloiwa; Benjamin M Kagina; Mark E Engel; Gregory D Hussey
Journal:  BMC Med       Date:  2020-08-28       Impact factor: 8.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.